All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for INFECTIOUS DISEASES SOCIETY OF AMERICA · Medical association promoting public health and prevention of infectious diseases

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $50,000.00 income · posted Jul 18, 2026

Official filing document

Bills named in this filing 5

HR 7352
PASTEUR Act of 2026
S 4875
PASTEUR Act of 2026
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
HR 4445
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
S 4283
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill

Budget/Appropriations

H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026)

Medicare/Medicaid

Medicare reimbursement regarding evaluation and management services by infectious disease physicians and practice expense policies Calendar Year 2027 Physician Fee Schedule

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.